Edesa Biotech, Inc.
EDSA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $14,256 | $12,946 | $5,620 |
| - Cash | $10,792 | $12,362 | $13,897 | $1,564 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $1,894 | -$951 | $4,056 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$26 | -$26 | -$25 | -$43 |
| % Margin | – | – | – | – |
| EBITDA | -$2,197 | -$1,695 | -$1,565 | -$1,574 |
| % Margin | – | – | – | – |
| Net Income | -$2,228 | -$1,749 | -$1,590 | -$1,617 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.32 | -0.25 | -0.3 | -0.48 |
| % Growth | -28% | 16.7% | 37.5% | – |
| Operating Cash Flow | -$1,721 | -$1,751 | -$2,333 | -$1,517 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1,721 | -$1,751 | -$2,333 | -$1,517 |